• Review Identifies Promising Blood-Based Biomarkers for CRC Screening

    A systematic review examined novel blood tests, including circulating tumor DNA (ctDNA), that could help detect colorectal cancer and precancerous conditions earlier through less invasive screening methods. (Clinical Colorectal Cancer)